Trials which randomize practices II: sample size

Family Practice
S M Kerry, J M Bland

Abstract

When practices are randomized in a trial and observations are made on the patients to assess the relative effectiveness of the different interventions, sample size calculations need to estimate the number of practices required, not just the total number of patients. Our aims were to introduce the methodology for appropriate sample size calculation and discuss the implications for power. A worked example from general practice is used. Designs which randomize practices are less powerful than designs which randomize patients to intervention groups, particularly where a large number of patients is recruited from each practice. Studies which randomize few practices should be avoided if possible, as the loss of power is considerable and simple randomization may not ensure comparability of intervention groups.

Citations

Apr 1, 2008·Journal of General Internal Medicine·Thomas E LoveUNKNOWN DIG-IT Investigators
Apr 12, 2000·Family Practice·M K CampbellM Eccles
Apr 3, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Eduardo Olano-EspinosaF J Ayesta
Mar 28, 2008·BMJ : British Medical Journal·Sandra EldridgeGene Feder
Apr 25, 2002·Journal of the American Medical Informatics Association : JAMIA·Jen-Hsiang ChuangDaniel F Heitjan
Nov 28, 2012·PLoS Medicine·Charles WeijerUNKNOWN Ottawa Ethics of Cluster Randomized Trials Consensus Group
Mar 5, 2004·American Journal of Public Health·David M MurrayJonathan L Blitstein
Jul 16, 2015·International Journal of Epidemiology·Clare RutterfordSandra Eldridge
Dec 16, 2003·Statistics in Medicine·Obioha C UkoumunneSusan Chinn
Sep 12, 2008·Pain Practice : the Official Journal of World Institute of Pain·Rod Taylor
Sep 9, 2010·International Journal of Cancer. Journal International Du Cancer·Lena DillnerSven Törnberg
Sep 17, 2004·Scandinavian Journal of Primary Health Care·Morten Bondo ChristensenFrede Olesen
Sep 2, 2009·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Takashi UsamiMayumi Mochizuki
Sep 1, 2006·International Journal of Epidemiology·Sandra M EldridgeSally Kerry
Jan 5, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Simon Gilbody, Paula Whitty
Nov 12, 2005·Clinical Trials : Journal of the Society for Clinical Trials·Sandra M EldridgeObioha C Ukoumunne
Dec 14, 2018·Journal of Aging and Health·Subashan PereraJennifer S Brach
Dec 13, 2000·Statistics in Medicine·D G Altman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.